Yuvanci (single tablet combination therapy [STCT] of macitentan and tadalafi) has been approved by the European Commission ...

Effective brand strategies are like a well-made jigsaw but they can end up looking nothing like the picture that was agreed ...

Public health, access to healthcare services, and food and nutrition are some of the most important issues facing people ...

Johnson & Johnson (J&J) and Legend Biotech have shared positive long-term results for their BCMA-directed T-cell ...

Women have played a crucial role in rare disease awareness and better care, overcoming gender biases and systemic challenges ...

Many initiatives have tried to address this partnership challenge: the Healthcare Communications Association’s (HCA) own ...

Ipsen’s Kayfanda (odevixibat) has been approved by the European Commission (EC) under exceptional circumstances to treat ...

More and more health data is being collected in the real-world about how that medicine works in a wider population than that ...

This Blood Cancer Awareness Month, we want to highlight the critical role of patient-centricity in building awareness, ...

Eli Lilly has announced that it is investing $4.5bn into a new US facility for advanced manufacturing and drug development. The Lilly Medicine Foundry will give the company the ability to research new ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) as an add-on maintenance treatment for chronic obstructive pulmonary disease (COPD). The ...

NHS England has announced that hundreds of babies have begun to be tested for over 200 genetic conditions as part of a study led by Genomics England. The Generation Study is evaluating the potential ...